Elekta AB PE Ratio 2013-2025 | EKTAY
Current and historical p/e ratio for Elekta AB (EKTAY) from 2013 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Elekta AB PE ratio as of July 02, 2025 is 17.24.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Elekta AB PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-07-01 | 5.00 | 20.00 | |
| 2025-01-31 | 5.83 | $0.25 | 23.34 |
| 2024-10-31 | 5.88 | $0.25 | 23.52 |
| 2024-07-31 | 6.05 | $0.28 | 21.61 |
| 2024-04-30 | 6.95 | $0.32 | 21.73 |
| 2024-01-31 | 7.22 | $0.36 | 20.06 |
| 2023-10-31 | 6.44 | $0.33 | 19.52 |
| 2023-07-31 | 7.56 | $0.28 | 27.00 |
| 2023-04-30 | 7.82 | $0.24 | 32.57 |
| 2023-01-31 | 6.64 | $0.22 | 30.18 |
| 2022-10-31 | 4.66 | $0.24 | 19.40 |
| 2022-07-31 | 6.44 | $0.33 | 19.53 |
| 2022-04-30 | 6.13 | $0.35 | 17.50 |
| 2022-01-31 | 9.00 | $0.34 | 26.47 |
| 2021-10-31 | 10.29 | $0.37 | 27.81 |
| 2021-07-31 | 12.81 | $0.36 | 35.59 |
| 2021-04-30 | 11.76 | $0.38 | 30.95 |
| 2021-01-31 | 12.60 | $0.27 | 46.66 |
| 2020-10-31 | 10.21 | $0.26 | 39.25 |
| 2020-07-31 | 8.86 | $0.21 | 42.17 |
| 2020-04-30 | 7.99 | $0.19 | 42.07 |
| 2020-01-31 | 9.81 | $0.34 | 28.86 |
| 2019-10-31 | 11.96 | $0.31 | 38.58 |
| 2019-07-31 | 12.19 | $0.33 | 36.94 |
| 2019-04-30 | 10.06 | $0.34 | 29.60 |
| 2019-01-31 | 11.29 | $0.36 | 31.36 |
| 2018-10-31 | 10.73 | $0.40 | 26.81 |
| 2018-07-31 | 11.80 | $0.40 | 29.50 |
| 2018-04-30 | 9.56 | $0.35 | 27.30 |
| 2018-01-31 | 7.99 | $0.21 | 38.06 |
| 2017-10-31 | 8.02 | $0.12 | 66.86 |
| 2017-07-31 | 7.97 | $0.06 | 132.85 |
| 2017-04-30 | 8.66 | $0.04 | 216.47 |
| 2017-01-31 | 7.36 | $0.03 | 245.39 |
| 2016-10-31 | 7.18 | $0.02 | 359.08 |
| 2016-07-31 | 6.58 | $0.06 | 109.61 |
| 2016-04-30 | 6.03 | $0.04 | 150.75 |
| 2016-01-31 | 6.13 | $0.13 | 47.13 |
| 2015-10-31 | 6.41 | $0.18 | 35.62 |
| 2015-07-31 | 5.45 | $0.19 | 28.70 |
| 2015-04-30 | 7.62 | $0.18 | 42.34 |
| 2015-01-31 | 8.76 | $0.38 | 23.05 |
| 2014-10-31 | 8.34 | $0.39 | 21.37 |
| 2014-07-31 | 9.78 | $0.39 | 25.07 |
| 2014-04-30 | 11.14 | $0.44 | 25.31 |
| 2014-01-31 | 11.64 | $0.47 | 24.76 |
| 2013-10-31 | 11.78 | $0.50 | 23.57 |
| 2013-07-31 | 13.32 | $0.53 | 25.12 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.918B | $1.708B |
| Elekta AB is a human care company engaged in developing and selling clinical solutions for the treatment of cancer and neurological diseases. It develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. The Company's offering is divided into five areas: Neuroscience, Oncology, Software, Brachytherapy and Services. Elekta AB is headquartered in Stockholm, Sweden. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $192.825B | 84.46 |
| Thermo Fisher Scientific (TMO) | United States | $159.102B | 19.25 |
| Edwards Lifesciences (EW) | United States | $45.274B | 29.68 |
| Alcon (ALC) | Switzerland | $43.909B | 29.67 |
| IDEXX Laboratories (IDXX) | United States | $43.641B | 50.15 |
| DexCom (DXCM) | United States | $32.772B | 50.65 |
| IQVIA Holdings (IQV) | United States | $28.132B | 15.76 |
| Mettler-Toledo (MTD) | United States | $25.049B | 29.79 |
| STERIS (STE) | Ireland | $23.871B | 26.29 |
| Waters (WAT) | United States | $21.247B | 29.98 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.939B | 0.00 |
| Hologic (HOLX) | United States | $14.558B | 15.82 |
| Sysmex ADR (SSMXY) | Japan | $10.852B | 30.79 |
| Penumbra (PEN) | United States | $9.708B | 76.19 |
| Masimo (MASI) | United States | $9.164B | 33.80 |
| Globus Medical (GMED) | United States | $8.150B | 19.42 |
| Glaukos (GKOS) | United States | $5.858B | 0.00 |
| Teleflex (TFX) | United States | $5.384B | 8.89 |
| TransMedics (TMDX) | United States | $4.401B | 95.66 |
| Integer Holdings (ITGR) | United States | $4.232B | 22.17 |
| PROCEPT BioRobotics (PRCT) | United States | $3.130B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.495B | 14.85 |
| Nihon Kohden (NHNKY) | Japan | $2.305B | 26.43 |
| Veracyte (VCYT) | United States | $2.140B | 30.02 |
| Alphatec Holdings (ATEC) | United States | $1.598B | 0.00 |
| Artivion (AORT) | United States | $1.313B | 123.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.148B | 0.00 |
| OPKO Health (OPK) | United States | $1.055B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.030B | 5.48 |
| Pulse Biosciences (PLSE) | United States | $0.998B | 0.00 |
| SiBone (SIBN) | United States | $0.780B | 0.00 |
| IRadimed (IRMD) | United States | $0.769B | 39.04 |
| Beta Bionics (BBNX) | United States | $0.604B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.579B | 9.01 |
| RxSight (RXST) | United States | $0.533B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.533B | 12.49 |
| OrthoPediatrics (KIDS) | United States | $0.531B | 0.00 |
| AxoGen (AXGN) | United States | $0.499B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.444B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.438B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.395B | 10.51 |
| Pacific Biosciences Of California (PACB) | United States | $0.387B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.387B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.379B | 0.00 |
| NeuroPace (NPCE) | United States | $0.344B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.315B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.265B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.238B | 14.41 |
| 908 Devices (MASS) | United States | $0.232B | 0.00 |
| Neuronetics (STIM) | United States | $0.228B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.227B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.210B | 0.00 |
| Inogen (INGN) | United States | $0.191B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.172B | 0.00 |
| CVRx (CVRX) | United States | $0.157B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.153B | 0.00 |
| LENSAR (LNSR) | United States | $0.151B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.134B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.119B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.106B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.102B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 46.40 |
| EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
| Spectral AI (MDAI) | United States | $0.068B | 0.00 |
| InspireMD (NSPR) | United States | $0.068B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.062B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.025B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.44 |